While Pfizer, Eli Lilly, J&J, GlaxoSmithKline and Sanofi-Aventis face expiring patents and a sizeable drop in rank in the coming years, Roche might hold strong and is poised to carry about 6 percent of the global prescription drug market in 2014. Ranked fifth in 2007, the company is also less at risk of losing revenue to genetic competitors. Report [1]
Links:
[1] http://blogs.wsj.com/health/2008/08/05/which-drugmaker-will-be-biggest-in-2014-hint-not-pfizer/?mod=googlenews_wsj